Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Ju Fu Tang Biotech Holdings Co's quarterly market cap
increased
from Mar. 2025 (HK$63.09 Mil) to Sep. 2025 (HK$78.48 Mil) and
increased
from Sep. 2025 (HK$78.48 Mil) to Mar. 2026 (HK$87.54 Mil).
Ju Fu Tang Biotech Holdings Co's annual market cap
increased
from Mar. 2024 (HK$26.56 Mil) to Mar. 2025 (HK$63.09 Mil) and
increased
from Mar. 2025 (HK$63.09 Mil) to Mar. 2026 (HK$87.54 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Ju Fu Tang Biotech Holdings Co's Enterprise Value for Today is HK$-16.66 Mil.
Ju Fu Tang Biotech Holdings Co (HKSE:08217) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Ju Fu Tang Biotech Holdings Co Market Cap Related Terms
Ju Fu Tang Biotech Holdings Co Market Cap Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HKSE:08217 vs PWR, FIX, EME: Market Cap Comparison
For the Engineering & Construction subindustry, Ju Fu Tang Biotech Holdings Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ju Fu Tang Biotech Holdings Co Market Cap vs Construction Industry
For the Construction industry and Industrials sector, Ju Fu Tang Biotech Holdings Co's Market Cap distribution charts can be found below:
* The bar in red indicates where Ju Fu Tang Biotech Holdings Co's Market Cap falls into.
Ju Fu Tang Biotech Holdings Co Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ju Fu Tang Biotech Holdings Co (HKSE:08217) has a Market Cap of HK$32.30 Mil as of Aug. 06, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Ju Fu Tang Biotech Holdings Co and its competitors. According to the industry distribution chart, Ju Fu Tang Biotech Holdings Co ranks #1715 out of 1814 companies in the Construction industry, placing it in the top 94.5%.
Is Ju Fu Tang Biotech Holdings Co's Market Cap too high?
Ju Fu Tang Biotech Holdings Co's current Market Cap is HK$32.30 Mil. Based on the distribution chart, Ju Fu Tang Biotech Holdings Co ranks #1715 out of 1814 companies in the Construction industry, which is in the bottom quartile relative to peers. Overall, Ju Fu Tang Biotech Holdings Co has a GF Score™ of 36/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Ju Fu Tang Biotech Holdings Co's Market Cap compare to PWR and FIX?
According to the Construction industry distribution chart, Ju Fu Tang Biotech Holdings Co ranks #1715 out of 1814 companies for Market Cap. This places Ju Fu Tang Biotech Holdings Co in the lower half of its industry. The industry median Market Cap is 119.57. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Construction company?
The median Market Cap among Construction companies is 119.57, based on 1,814 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Ju Fu Tang Biotech Holdings Co and its competitors. For the Construction industry, the median Market Cap is 119.57 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ju Fu Tang Biotech Holdings Co's current Market Cap is HK$32.30 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ju Fu Tang Biotech Holdings Co stock overvalued right now?
Based on GuruFocus' analysis, Ju Fu Tang Biotech Holdings Co (HKSE:08217) is currently considered Modestly Undervalued. The stock's GF Value™ is HK$0.15, compared to a current price of HK$0.11 — trading 28.7% below its estimated fair value. The current Market Cap is HK$32.30 Mil. Ju Fu Tang Biotech Holdings Co's overall GF Score™ is 36/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Ju Fu Tang Biotech Holdings Co (HKSE:08217), the current Market Cap is HK$32.30 Mil as of Aug. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ju Fu Tang Biotech Holdings Co (HKSE:08217) Overvalued in 2026?
Based on GuruFocus' analysis, Ju Fu Tang Biotech Holdings Co stock appears to be undervalued.
The current stock price of HK$0.11 is trading 28.7% below its estimated GF Value™ of HK$0.15.
GuruFocus considers Ju Fu Tang Biotech Holdings Co to be Modestly Undervalued.
Key valuation signals for HKSE:08217:
Market Cap: HK$32.30 Mil
GF Value™: HK$0.15 vs. price of HK$0.11 (28.7% below fair value)
No single metric tells the full story. See the HKSE:08217 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ju Fu Tang Biotech Holdings Co Ltd, formerly known as WMHW Holdings Ltd, is an investment holding company operating through its subsidiaries. It engaged in the provision of construction works and investment holding.
36GF Score
Get the complete analysis for HKSE:08217
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:08217 has been successfully added to your 
